Skip to main content
. 2022 Jun 17;13:845136. doi: 10.3389/fpsyt.2022.845136

Table 3.

Psychotropic medications in the study group.

Second-generation antipsychotics 57 (95.0%) [0.86–0.99]
First-generation antipsychotics 22 (36.7%) [0.25–0.50]
>1 medication 40 (66.7%) [0.53–0.78]
Mood stabilizers 25 (41.7%) [0.29–0.55]
    Lamotrigine 11 (18.3%)
    Valproate 11 (18.3%)
Antidepressants 8 (13.3%) [0.06–0.25]

Data given as n (%) [95% CI].